GLP-1 Microdosing, Brain Health, and Alzheimers Prevention: What the Evidence Actually Shows AI Overview GLP-1 medications such as semaglutide and tirzepatide are being studied for more than weight loss
Conclusion: Beyond the Scale The excitement around GLP-1 medications started with weight loss, but the science is showing us a much bigger picture
This finding helped establish GLP-1 medications as legitimate cardiovascular protective agents, not just weight loss drugs
Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
Despite many online success stories claiming it heals bones, joints, and stomach ulcers, there is no solid scientific evidence to back this up
The need for lifestyle changes in addition to medicine is also emphasized in the study as a key component of effective weight management